1. 103041388 仔猪大肠杆菌病卵黄免疫球蛋白生物制剂及其制备工艺
CN
17.04.2013
A61K 39/40 Loading...
A61K 39/40
Loading...
201310019642.1
辽宁益康生物股份有限公司
苗玉和
A61K 39/40
Loading...
本发明提供一种仔猪大肠杆菌病卵黄免疫球蛋白生物制剂，它由以下重量份的组分组成：糖萜素5.0~55.0，莨菪碱0.005~0.01，活菌益生素5.0~55.0和卵黄免疫球蛋白50.0~95.0。本发明的制剂具有更高的稳定性，对大肠杆菌的抑杀作用更加持久充分，抗感染效果更加显著，因此更能够达到防治仔猪大肠杆菌腹泻的目的。同时本发明的制剂是一种纯天然、无药残、无公害、无耐药性、无毒副作用的环保型绿色抗感染药物，又是现有各种不良抗生药物的优秀替代药品。
2. 103007280 仔猪大肠杆菌病冻干血清免疫球蛋白制剂及其制备工艺
CN
03.04.2013
A61K 39/40 Loading...
A61K 39/40
Loading...
201310019656.3
辽宁益康生物股份有限公司
李尚波
A61K 39/40
Loading...
本发明提供一种仔猪大肠杆菌病冻干血清免疫球蛋白制剂，它由以下重量份的组分组成：糖萜素5.0~55.0，莨菪碱0.005~0.01，血清免疫球蛋白55.0~95.0。本发明的制剂具有更高的稳定性，对大肠杆菌的抑杀作用更加持久充分，抗感染效果更加显著，因此更能够达到防治仔猪大肠杆菌腹泻的目的。同时本发明的制剂是一种纯天然、无药残、无公害、无耐药性、无毒副作用的环保型绿色抗感染药物，又是现有各种不良抗生药物的优秀替代药品。
3. 201634611 一种卵黄酸化分层抗体提取罐
CN
17.11.2010
C07K 16/02 Loading...
C07K 16/02
Loading...
200920278903.0
辽宁益康生物制品有限公司
马成国
C07K 16/02
Loading...
本实用新型涉及一种卵黄酸化分层抗体提取罐。包括罐体、计算机及相关自动控制电磁阀组，其罐体顶部设置有双金属温度表、机械搅拌设备、清洗器、热蒸汽入口，机械搅拌设备的搅拌器伸入罐体内，所述的罐体顶部设置有计量进料部件，其计量进料管伸入内胆，所述的罐体下1/3处设置有旋转出料部件，其旋转出料管伸入内胆，旋转出料管与旋转出料管电机联接；可针对不同物料的沉淀程度，自动控制电磁阀门调节旋转出液口方向，实现澄清卵黄抗体液分层抽取、分层上清液最大量排出；集同一罐体在位冷藏、在位灭菌、自动控温、自动控制配比浓度、混合搅拌、分层出液等功能于一体，减少不同规格罐体的配置，换热效率高，控温准确，分层效果好。
4. 201558312 抗体复合制剂合成装置
CN
25.08.2010
A61J 3/00 Loading...
A61J 3/00
Loading...
200920278788.7
辽宁益康生物制品有限公司
苗玉和
A61J 3/00
Loading...
本实用新型一种抗体复合制剂合成装置，包括：罐体、支架，其特征在于：所述的罐体侧周为夹套的密闭容器、在夹套中的制冷或制热盘管缠绕在罐体内胆外侧，罐体内胆中间设置搅拌器，罐体内胆顶部分别设置电磁阀的抗体进料口、中药多糖进料口及温度计和温度探头、检查入口、在位清洗球、呼吸器、热蒸汽入口；在罐体侧面分别设置电磁阀的乙二醇进口及乙二醇出口，罐体内胆底部设置电磁阀的出料口，支架底部设置称重模块，自动控制器分别连接搅拌器的开关、制冷或制热盘管、称重模块、温度计和温度探头及上述的电磁阀。它具有功能齐全，实现在位低温冷藏并精确控温：自动化生产：对罐体内加温及低温冷却的精确控温，精确配料，大大提高了产品质量。
5. 201541652 一种卵黄卵清分离机
CN
11.08.2010
A23J 1/09 Loading...
A23J 1/09
Loading...
200920278902.6
辽宁益康生物制品有限公司
马成国
A23J 1/09
Loading...
本实用新型涉及一种卵黄卵清分离机。包括机体、卵清收集槽、卵黄收集槽，其机体上设置有调节装置，调节装置联接分离板的高端，分离板中部通过铰链与机体铰接，分离板下方设置有卵清收集槽，分离板的低端下方设置有卵黄收集槽；可以方便快捷地对卵清卵黄进行分别分离、收集，分离彻底，回收率高，卵清通过割线彻底与卵黄完全分离并收集；经分离后的卵黄，膜完整，反光性强，光洁度高，膜上卵清残留量很少，得到的卵黄液中卵黄的纯度达到90％以上，达到了药品生产的技术分离指标，纯度及效价提高；本机易于操作，便于大批量产业化生产。
6. 101690821 Immune protective agent of attenuated living vaccine against infectious bursal disease and preparation method thereof
CN
07.04.2010
A61K 47/42 Loading...
A61K 47/42
Loading...
200910180914.X
Liaoning Yikang Biological Products Co., Ltd.
Miao Yuhe
A61K 47/42
Loading...
The invention provides an immune protective agent of an attenuated living vaccine against infectious bursal disease, which consists of the following components in part by weight: 8 parts of Chinese medicinal polysaccharide, 1 part of Chinese medicinal saponin and 1 part of casein, wherein the Chinese medicinal polysaccharide and the Chinese medicinal saponin are extracted from the following Chinese medicinal raw materials in part by weight: 30 parts of szechwon tangshen root, 20 parts of largehead atractylodes rhizome, 15 parts of agaric, 15 parts of oriental waterplantain rhizome, 10 parts of Indian buead and 10 parts of plantain herb. The immune protective agent is mainly embodied in that specific Chinese medicinal effective components guide immunogen to generate specific immunoreactions on a specific organism part, is also embodied in that the immune protective agent has specific protection effect on the immunogen in the whole process of processing, storing and using the vaccine, and has a scientific formula for integrating channel tropism of Chinese medicines, immunoadjuvant and immunogen protective agent for the first time.
7. 101690810 Tetravalent inactivated vaccine adjuvant against Newcastle Disease, infectious bronchitis, egg drop syndrome and bird flu and preparation method thereof
CN
07.04.2010
A61K 39/39 Loading...
A61K 39/39
Loading...
200910180913.5
Zhang Yongfei
Zhang Yongfei
A61K 39/39
Loading...
The invention provides a tetravalent inactivated vaccine adjuvant against Newcastle Disease, infectious bronchitis, egg drop syndrome and bird flu, which consists of the following components in part by weight: 9.5 parts of Chinese medicinal polysaccharide, 0.5 part of Chinese medicinal saponin and 30 parts of Tween-20, wherein the Chinese medicinal polysaccharide and the Chinese medicinal saponin are all extracted from the following Chinese medicinal raw materials in part by weight: 100 parts of platycodon root, 80 parts of pinellia tuber, 80 parts of baical skullcap root, 80 parts of honeysuckle, 80 parts of weeping forsythiae capsule, 65 parts of dwarf lilyturf tuber, 40 parts of vietnamese sophora root, 50 parts of liquorice, 80 parts of red paeony root, 60 parts of figwort root, 80 parts of white paeony root, 45 parts of fresh rehmannia, 90 part of indigowoad root, 75 parts of tree peony bark and 60 parts of golden thread. The vaccine adjuvant has obvious protection effect on immunogen in the processes of processing, storing and using vaccine, can guide the immunogen to generate specific immunoreactions on a specific organism part, and achieves the aim of integrating channel tropism of Chinese medicines, immunoadjuvant and immunogen protective agent.
8. 101690811 Concentrated freeze-dried yolk antibody composite preparation for infectious bursal disease and preparation process thereof
CN
07.04.2010
A61K 39/395 Loading...
A61K 39/395
Loading...
200910180910.1
Liaoning Yikang Biological Products Co., Ltd.
Li Shangbo
A61K 39/395
Loading...
The invention provides a concentrated freeze-dried yolk antibody composite preparation for infectious bursal disease, which contains the following components in part by weight: 10.0 to 99.5 parts of infectious bursal disease virus resistant yolk antibody and 0.5 to 20.0 parts of Chinese medicinal polysaccharide, wherein the Chinese medicinal polysaccharide is extracted from one or a composition of more than two of the following Chinese medicines in part by weight: 10 to 50 parts of Chinese angelica, 50 to 100 parts of szechwon tangshen root, 50 to 80 parts of membranous milkvetch root and 30 to 50 parts of Indian buead. The preparation is a freeze-dried preparation prepared by combining the components such as the infectious bursal disease virus resistant yolk antibody and the polysaccharide under the guidance of immunity engineering of Chinese medical science, is clinically used for the infectious bursal disease, has the effect of treating infectious bursal disease virus infection, and excites the immunity and disease resistance of organisms; and simultaneously, the polysaccharide component in the preparation has powerful protection effect on the yolk antibody.
9. 101690813 Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease and preparation process thereof
CN
07.04.2010
A61K 39/395 Loading...
A61K 39/395
Loading...
200910180912.0
Liaoning Yikang Biological Products Co., Ltd.
Li Shangbo
A61K 39/395
Loading...
The invention provides a concentrated and freeze-dried yolk antibody composite preparation for Newcastle disease, which comprises the following components in part by weight: 10.0 to 99.5 parts of Newcastle disease virus resistant yolk antibody and 0.5 to 20.0 parts of Chinese medicinal polysaccharide. The preparation is a freeze-dried preparation prepared by combining the components such as the Newcastle disease virus resistant yolk antibody and the polysaccharide under the guidance of immunity engineering of Chinese medical science, is clinically used for the Newcastle disease, has the effect of treating Newcastle disease virus infection, and excites the immunity and disease resistance of organisms; and simultaneously, the polysaccharide component in the preparation has powerful protection effect on the yolk antibody.
10. 101690812 Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease-infectious bursal disease and preparation process thereof
CN
07.04.2010
A61K 39/395 Loading...
A61K 39/395
Loading...
200910180911.6
Liaoning Yikang Biological Products Co., Ltd.
Miao Yuhe
A61K 39/395
Loading...
The invention provides a concentrated freeze-dried yolk antibody composite preparation for Newcastle disease-infectious bursal disease, which contains the following components in part by weight: 10.0 to 99.5 parts of Newcastle disease-infectious bursal disease virus resistant yolk antibody and 0.5 to 20.0 parts of Chinese medicinal polysaccharide, wherein the Chinese medicinal polysaccharide is extracted from one or a composition of more than two of the following Chinese medicines in part by weight: 10 to 50 parts of indigowoad root, 50 to 100 parts of fresh rehmannia, 50 to 80 parts of danshen root and 30 to 50 parts of liquorice. The preparation is a freeze-dried preparation prepared by combining the components such as the Newcastle disease-infectious bursal disease virus resistant yolk antibody and the polysaccharide under the guidance of immunity engineering of Chinese medical science, is clinically used for the Newcastle disease-infectious bursal disease, has the effect of treating the Newcastle disease-infectious bursal disease virus infection, and excites the immunity and disease resistance of organisms; and simultaneously, the polysaccharide component in the preparation has powerful protection effect on the yolk antibody.

